Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
Schiller
KOREA E & EX

Gold Nanoparticles Prevent Infection on Orthopedic Implants

By HospiMedica International staff writers
Posted on 23 Jul 2014
Gold (Au) nanoparticles help prevent the formation of antibiotic resistant biofilm on the surface of orthopedic implants, according to a new study.

Researchers at the Shanghai Institute of Ceramics (CIS; China) extrapolated that since gold nanoparticles can pass electrons to titanium dioxide (TiO2), they could be used to induce bacterial death. Due to a phenomenon known as localized surface plasmon resonance (a collective oscillations of electrons), an Au@TiO2 system could effectively kill bacteria in darkness by affecting respiratory electrons of the bacterial membrane, making them steadily lose electrons by transferring them first to the Au nanoparticles and then to TiO2, until they die.

To do so, they prepared close-packed TiO2 nanotube arrays on a metallic Ti surface by electro-chemical anodization. Then, using magnetron sputtering, they deposited Au nanoparticles to coat the Ti surfaces. The researchers then allowed Staphylococcus aureus and Escherichia coli to grow separately on the arrays. They found that both organisms were highly unsuccessful, exhibiting profuse membrane damage and cell leakage. The study describing the technology was published on June 30, 2014, in the journal Applied Physics Letters.

“Implant-associated infections have become a stubborn issue that often causes surgery failure. Designing implants that can kill bacteria while supporting bone growth is an efficient way to enhance in vivo osteointegration,” concluded senior author Prof. Xuanyong Liu, PhD. “This work provides insights for the better understanding and designing of noble metal nanoparticles-based plasmonic heterostructures for antibacterial application.”

TiO2 is able to kill bacteria itself due to its properties as a photocatalyst; when the metal is exposed to light, it becomes energetically excited by absorbing photons. This generates electron-hole pairs, turning Ti into a potent electron acceptor that can destabilize cellular membrane processes by usurping their electron transport chain's terminal acceptor. The dark conditions inside the human body, however, limit the bacteria-killing efficacy of TiO2. Gold nanoparticles, though, can continue to act as antibacterial terminal electron acceptors under darkness, due to localized surface plasmon resonance at the interface between conductors and dielectrics, such as between gold and TiO2.

Related Links:

Shanghai Institute of Ceramics




JD Honigberg International
Anetic Aid
Inditherm
RG Advertising

Channels

Critical Care

view channel

Little Evidence Supports Opioid Use for Chronic Pain

A new study reveals that there is paltry evidence for the long-term safety and efficacy of opioids in the treatment of chronic pain. Researchers at the Oregon Health & Science University (OHSU; Portland, USA) and the University of Washington (Seattle, USA) searched MEDLINE, the Cochrane Central Register of Controlled... Read more

Women's Health

view channel

Pregnant Women in Austria Experience Iodine Deficiency

A new study suggests that pregnant women in Austria have a potentially clinically significant iodine deficiency which could impair embryonic brain development. Researchers at the Medical University of Vienna (Austria) conducted a cross-sectional investigation of urinary iodine excretion in 246 pregnant women (2 in the... Read more

Health IT

view channel

Computer Model Predicts Public Response to Disease Outbreaks

A new computer model could help public health officials anticipate public reactions to disease outbreaks, based on a combination of data collected from hospitals, social media, and other sources. Researchers at MIT (Cambridge, MA, USA), the Draper Laboratory (Cambridge, MA, USA), and Ascel Bio (Larchmont, NY, USA),... Read more

Business

view channel

Abbott Completes Topera Acquisition

Abbott (Abbott Park, IL, USA) has completed its acquisition of Topera (Menlo Park, CA, USA), developer of innovative electrophysiology technologies for the diagnosis and treatment of atrial fibrillation (AF). The Topera rotor identification system helps physicians identify and target patient-specific rotors that have... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.